This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Frontiers in Cardiovascular Medicine
MARCH 3, 2025
BackgroundVericiguata novel oral soluble guanylate cyclase stimulatorwas developed for the treatment of chronic heart failure (HF).
84 
Becker's Hospital Review - Cardiology
SEPTEMBER 3, 2024
Chicago-based Northwestern Memorial Hospital and VA Boston Healthcare System-Jamaica Plain (Mass.) have the lowest death rate for heart failure patients in the country, according to CMS data.
124 
American College of Cardiology
MARCH 30, 2025
25 in Chicago and simultaneously published in JAMA.
HCPLive
MAY 20, 2024
A numerically slower decline in eGFR was reported in the finerenone cohort after hospitalization for heart failure when compared with placebo.
116 
The British Journal of Cardiology
JANUARY 14, 2025
Heart failure (HF) is a significant problem in the UK with variation in services across the country. Seventy-nine responses describing hospital-based HF services from all devolved countries were received. The clinical lead in 82% of hospitals was a cardiologist with specialist interest in HF. and 75%, respectively.
Becker's Hospital Review - Cardiology
JANUARY 27, 2025
In partnership with Abbott, the American Heart Association has launched a $3 million initiative to address knowledge gaps found within heart failure treatment education that may be contributing to cardiovascular care disparities.
115 
HCPLive
FEBRUARY 8, 2024
Deepak Bhatt, MD, MPH, discusses the need to improve in-hospital initiation and uptitration of guideline-directed medical therapy in heart failure.
130 
Becker's Hospital Review - Cardiology
AUGUST 14, 2024
Luke's Regional Medical Center has the lowest readmission rate for heart failure patients, CMS found. Boise, Idaho-based St.
116 
Medical Xpress - Cardiology
JANUARY 31, 2025
People hospitalized for infectionsalmost any infectionsare at substantially increased risk years later for heart failure, according to collaborative research by the University of Minnesota and Mayo Clinic.
124 
European Journal of Heart Failure
JANUARY 20, 2025
Remote patient monitoring in heart failure (HF). Abstract Aims Methods of non-invasive remote patient monitoring (RPM) for heart failure (HF) remain diverse. 95% confidence interval [CI] 0.690.95; I 2 =0.39) and reduced first HF hospitalization risk (pooled OR 0.78, 95% CI: 0.700.87; I 2 =0.21) compared to usual care.
Science Daily - Heart Disease
JANUARY 19, 2025
People with pockets of fat hidden inside their muscles are at a higher risk of dying or being hospitalized from a heart attack or heart failure, regardless of their body mass index, according to new research. This 'intermuscular' fat is highly prized in beef steaks for cooking.
114 
Science Daily - Heart Disease
APRIL 25, 2024
A multicenter study has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.
120 
DAIC
MARCH 26, 2025
Food and Drug Administration (FDA) accepted its supplemental new drug application (sNDA) and granted Priority Review designation for KERENDIA(finerenone) for the treatment of adult patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40%, i.e., mildly reduced LVEF (HFmrEF) or preserved LVEF (HFpEF).
DAIC
JULY 31, 2024
mtaschetta-millane Wed, 07/31/2024 - 06:00 July 31, 2024 — A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & Vascular Institute, demonstrates the effectiveness of a newly developed scoring system in identifying patients with Heart Failure with Preserved Ejection Fraction (HFpEF).
111 
Science Daily - Heart Disease
SEPTEMBER 2, 2024
Finerenone reduced the composite of total first and recurrent heart failure (HF) events (hospitalizations for HF or urgent HF visits) and cardiovascular death in patients with HF and mildly reduced or preserved ejection fraction, according to an international clinical trial.
HCPLive
FEBRUARY 12, 2025
Meta-analysis suggests iron therapy lowers the risk of heart failure hospitalization and cardiovascular death in patients with chronic kidney disease.
120 
DAIC
MARCH 6, 2024
a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care. Bodyport Inc., Image courtesy: Bodyport Inc.
128 
DAIC
APRIL 30, 2024
Getty Images milla1cf Tue, 04/30/2024 - 12:56 April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center ( VUMC ) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure , a leading cause of hospitalization and death.
105 
Frontiers in Cardiovascular Medicine
MARCH 5, 2025
BackgroundHeart failure (HF), a global health challenge, is a leading cause of mortality in hospitalized patients. The association between ACC and clinical outcomes in HF patients was analyzed using Cox proportional hazards regression and restricted cubic spline models.ResultsA total of 4,737 heart failure patients were included.
DAIC
MAY 2, 2024
(‘Reprieve’), a development stage company focused on pioneering an intelligent approach to acute decompensated heart failure (ADHF) treatment, today highlighted the publication of TREAT-AHF study results in JACC: Heart Failure. Heart failure (HF) is a leading cause of hospitalization in the United States.
105 JAMA Cardiology
DECEMBER 26, 2023
This secondary analysis of the Safety, Tolerability, and Efficacy of Rapid Optimization, Helped by N-Terminal Pro–Brain Natriuretic Peptide Testing of Heart Failure Therapies (STRONG-HF) randomized clinical trial investigates what variables are associated with success in uptitration of guideline-directed medical therapy after hospital discharge for (..)
107 
DAIC
FEBRUARY 12, 2024
A team at Allina Health’s Abbott Northwestern Hospital has successfully completed the first Barostim Baroreflex Activation Therapy implant in the state of Minnesota, according to an announcement from CVRx, Inc. and Allina Health. and Allina Health. and Allina Health. The Minneapolis, MN-based company received U.S.
104 
Heart BMJ
FEBRUARY 12, 2025
In adults with congenital heart disease (ACHD patients), atrial arrhythmias (AA) and heart failure (HF) are common. Of these, AA is one of the leading causes for hospital admissions in ACHD care.
Medical Xpress - Cardiology
JULY 29, 2024
A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & Vascular Institute demonstrates the effectiveness of a newly developed scoring system in identifying patients with Heart Failure with Preserved Ejection Fraction (HFpEF).
Open Heart
FEBRUARY 27, 2025
Background Iron deficiency (ID) is a highly prevalent comorbidity in patients with chronic and acute heart failure and is associated with worse clinical outcomes. We aimed to evaluate the prevalence and clinical characteristics of ID and its association with in-hospital congestion and postdischarge outcomes.
Cardiology Update
JANUARY 22, 2024
The Resynchronization–Defibrillation for Ambulatory Heart Failure Trial (RAFT; NCT00251251 ) demonstrated a greater 5-year mortality benefit for patients receiving cardiac-resynchronization therapy (CRT) compared to those receiving implantable cardioverter–defibrillators (ICDs). The median follow-up duration for these patients was 7.7
115 
HCPLive
APRIL 7, 2024
Veraprapas Kittipibul, MD, discusses a study examining costs associated with heart failure hospitalization among patients with HFrEF or HFpEF from within the GWTG-HF registry.
European Journal of Heart Failure
MARCH 12, 2025
Patients with heart failure (HF) experience much worse QoL and effort intolerance than both the general population and people with other chronic conditions, since they present a range of physical and psychological symptoms, including shortness of breath, chest discomfort, fatigue, fluid congestion, trouble with sleeping, and depression.
Becker's Hospital Review - Cardiology
OCTOBER 8, 2024
based UMass Memorial Health-Harrington Hospital reduced the all-cause 30-day readmission for heart failure patients by 50% as part of a remote patient monitoring program with digital health company Brook Health. Southbridge, Mass.-based
Becker's Hospital Review - Cardiology
NOVEMBER 25, 2024
Of those, 97 hospitals were recognized for delivering superior clinical outcomes in cardiac care for heart bypass surgery, coronary interventional procedures, heart attack treatment, heart failure treatment and heart valve surgery. Healthgrades published its 2025 Specialty Excellence Awards recipients Oct.
105 
DAIC
JULY 30, 2024
This study by Fujita Health University researchers revealed that kidney function, considered in terms of estimated glomerular filtration rate (eGFR), can be used as a predictor for SCD in patients with congestive heart failure. During the follow-up period, 198 of these patients suffered from SCD.
Cardiology Update
APRIL 25, 2024
RELIEVE-HF investigators evaluated the efficacy and safety of the V-wave interatrial shunt system in patients with heart failure. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. Atlanta, GA.
Frontiers in Cardiovascular Medicine
JANUARY 23, 2025
Background Early prediction of heart failure (HF) after acute myocardial infarction (AMI) is essential for personalized treatment. The primary endpoint was the occurrence of HF within 3 years after operation.
DAIC
SEPTEMBER 19, 2024
recently announced that Digitiva, a non-invasive digital health solution for heart failure management, has been listed with the U.S. a smartphone app designed for heart failure patients and built on the Welldoc, Inc. tim.hodson Thu, 09/19/2024 - 09:42 Sept. 18, 2024 – Astellas Pharma Inc.
105 
DAIC
FEBRUARY 26, 2024
milla1cf Mon, 02/26/2024 - 12:40 February 26, 2024 — More than 6 million Americans live with heart failure , and about half have an enlarged left ventricle, which causes stress on the heart and less blood pumped with each heartbeat. Patients may experience trouble breathing and fatigue, and at times require hospitalization.
119 
European Journal of Heart Failure
FEBRUARY 16, 2025
Baseline characteristics for the vericiguat global study in participants with chronic heart failure (VICTOR) trial. of participants had no prior hospitalization for heart failure. Conclusion The VICTOR trial enrolled the most optimally treated population in a phase III heart failure trial.
European Journal of Heart Failure
MARCH 10, 2025
Association of clonal haematopoiesis with heart failure incidence and outcomes: A systematic review and meta-analysis. Clonal haematopoiesis and heart failure: a meta-analysis. CH, clonal haematopoiesis; CI, confidence interval; HF, heart failure.
DAIC
FEBRUARY 6, 2024
Matthew Segar co-authored a study in JACC Heart Failure led by his research and residency mentor, University of Texas Southwestern Medical Center's Dr. Ambarish Pandey , that utilized a machine learning-based-approach to identify, understand, and predict diuretic responsiveness in patients with acute decompensated heart failure (ADHF).
111 
Becker's Hospital Review - Cardiology
APRIL 3, 2024
The FDA has approved an artificial intelligence algorithm for Eko Health's digital stethoscope that can detect low ejection fraction, a key indicator of heart failure.
115 115 
Becker's Hospital Review - Cardiology
SEPTEMBER 16, 2024
Discover the top 10 hospitals with the highest excess readmission rates for heart failure patients, according to CMS' hospital readmissions reduction program
HCPLive
JANUARY 25, 2024
Lower levels of selenoprotein P were associated with reduced hemoglobin, greater transferrin receptor 1, and an increased prevalence of anemia in a cohort of hospitalized heart failure patients.
Science Daily - Heart Disease
MARCH 17, 2025
Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalization if they stop taking heart failure medications.
DAIC
JUNE 21, 2024
announced that the peer-reviewed Journal of the American College of Cardiology: Heart Failure has published a research paper concluding that INPEFA (sotagliflozin) is cost-effective for people with diabetes and recent worsening heart failure using commonly accepted willingness-to-pay thresholds. “Our healthcare system.
105 
DAIC
APRIL 3, 2024
healthcare providers can now detect Low EF, a key heart failure indicator, in 15 seconds using an Eko stethoscope during a routine physical examination. As a result, many heart failure cases go undiagnosed until symptoms force a specialist or emergency hospital visit, leading to worse patient outcomes and exacerbated healthcare costs.2
111
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content